Liu Gene
Visual SEC Form 4 history across 1 companies, 27 transactions and 6 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
No open-market insider purchase is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| TEAM | LIU GENE | CAO | sale10b5-1 | 939 | -$17.8M | S | 0.0% | 08/31 | 08/28 | |
| TEAM | LIU GENE | CAO | sale10b5-1 | 1.12k | -$19.6M | S | +6.9% | 08/20 | 08/19 | |
| TEAM | LIU GENE | CAO | sale10b5-1 | 25 | -$412k | S | +18.1% | 08/17 | 08/14 | |
| TEAM | LIU GENE | CAO | sale10b5-1 | 125 | -$2.05M | S | +18.1% | 08/17 | 08/14 | |
| TEAM | LIU GENE | CAO | sale10b5-1 | 157 | -$2.56M | S | +18.1% | 08/17 | 08/14 | |
| TEAM | LIU GENE | CAO | sale10b5-1 | 492 | -$7.98M | S | +18.1% | 08/17 | 08/14 | |
| TEAM | LIU GENE | CAO | sale10b5-1 | 3 | -$50.1k | S | +18.1% | 08/17 | 08/14 | |
| TEAM | LIU GENE | CAO | sale10b5-1 | 13 | -$216k | S | +18.1% | 08/17 | 08/14 | |
| TEAM | LIU GENE | CAO | sale10b5-1 | 737 | -$12.1M | S | +18.1% | 08/17 | 08/13 | |
| TEAM | LIU GENE | CAO | sale | 5 | -$152k | S | — | 02/20/2025 | 02/19/2025 |
Liu Gene Insider Activity FAQ
SEC Form 4 context
Who is Liu Gene?
Liu Gene is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001946411.
Which companies has Liu Gene reported transactions for?
Atlassian Corp
When was Liu Gene's latest insider buy?
No open-market insider purchase is available for this period.
When was Liu Gene's latest insider sale?
sale at Atlassian Corp on Aug 28, 2026 valued at $178,410.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.